Trial intelligence / Profile preview

Celebrex in oral surgery pain

NCT00006299Phase 2Completed

Sponsor
National Institute of Dental and Craniofacial Research
Start
Dec 1999
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of celecoxib in postoperative pain (3 arms), sponsored by National Institute of Dental and Craniofacial Research. Primary endpoint: Pain intensity and relief scores at 6 hours. Started Dec 1999; status: completed.

02

Drugs

celecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00006299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call